{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:17:01Z","timestamp":1788999421771,"version":"build-2803163510"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/wnf.0b013e31823429bd","type":"journal-article","created":{"date-parts":[[2011,11,19]],"date-time":"2011-11-19T09:18:36Z","timestamp":1321694316000},"page":"256-257","source":"Crossref","is-referenced-by-count":26,"title":["Aripiprazole Improves Olanzapine-Associated Obsessive Compulsive Symptoms in Schizophrenia"],"prefix":"10.1097","volume":"34","author":[{"given":"Sandra","family":"Sch\u00f6nfelder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederike","family":"Schirmbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Waltereit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Englisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Zink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"11","key":"R1-10-20210203","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1017\/S0033291711000419","article-title":". Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia.","volume":"41","author":"Schirmbeck","year":"2011","journal-title":"Psychol Med"},{"key":"R3-10-20210203","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0278-5846(03)00039-3","article-title":". Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases.","volume":"27","author":"Lykouras","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R4-10-20210203","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/00048670601172806","article-title":"Management of clozapine-induced obsessive compulsive symptoms in a man with schizophrenia.","volume":"41","author":"Zink","year":"2006","journal-title":"Austr NZ J Psychiatry"},{"key":"R5-10-20210203","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.pnpbp.2006.03.024","article-title":"Benefits of combining aripiprazole to clozapine: three case reports.","volume":"30","author":"Rocha","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R6-10-20210203","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4088\/JCP.v69n0505","article-title":". Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.","volume":"69","author":"Chang","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R7-10-20210203","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/WNF.0b013e31819cc8e6","article-title":". Clozapine-induced obsessive compulsive syndromes improve in combination with aripiprazole.","volume":"32","author":"Englisch","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"R8-10-20210203","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.pnpbp.2008.02.010","article-title":"Combined antipsychotic treatment involving clozapine and aripiprazole.","volume":"32","author":"Englisch","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R9-10-20210203","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4088\/JCP.09r05060gre","article-title":". A systematic review of aripiprazoledose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring.","volume":"71","author":"Sparshatt","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R10-10-20210203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2008.06.100","article-title":". Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.","volume":"592","author":"Egashira","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R11-10-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/FBP.0b013e3282f62cb2","article-title":". Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice.","volume":"19","author":"Bruins Slot","year":"2008","journal-title":"Behav Pharmacol"},{"key":"R13-10-20210203","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00023210-200822060-00003","article-title":". Pharmacological management of atypical antipsychotic-induced weight gain.","volume":"22","author":"Baptista","year":"2008","journal-title":"CNS Drugs"},{"key":"R14-10-20210203","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/YIC.0b013e3282f424d6","article-title":". Weight gain during olanzapine treatment for psychotic depression: effects of dose and age.","volume":"23","author":"Smith","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"R15-10-20210203","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/070674370404900213","article-title":"Aripirazole-olanzapine combination for treatment of schizophrenia.","volume":"49","author":"Duggal","year":"2004","journal-title":"Can J Psychiatry"},{"key":"R16-10-20210203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2710.2007.00806.x","article-title":"Hyperprolactinemia and amenorrhea associated with olanzapine normalized after addition of aripiprazole.","volume":"32","author":"Wolf","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"R17-10-20210203","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/JCP.0b013e31814fb9a3","article-title":"Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.","volume":"27","author":"Chen","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R18-10-20210203","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-0029-1202262","article-title":". Aripiprazole for the management of olanzapine-induced weight gain.","volume":"42","author":"Englisch","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"R19-10-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/JCP.0b013e31819a8dbe","article-title":". Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.","volume":"29","author":"Henderson","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R20-10-20210203","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/archgenpsychiatry.2007.3","article-title":". Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.","volume":"65","author":"Cannon","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"R21-10-20210203","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.4088\/JCP.v69n0702","article-title":". A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine.","volume":"69","author":"Newcomer","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R22-10-20210203","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.biopsych.2008.07.033","article-title":". A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia.","volume":"65","author":"Fleischhacker","year":"2009","journal-title":"Biol Psychiatry"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002826-201111000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:52:34Z","timestamp":1618278754000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201111000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31823429bd","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}